PMN|ProMIS Neurosciences Inc|Price:11.655|Chg%:-0.545
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company focused on developing antibody therapeutics for neurodegenerative diseases like Alzheimer's, ALS, and MSA. The company utilizes a proprietary computational platform to identify disease-specific epitopes and has product candidates such as PMN310, PMN267, and PMN442 in development. …